Benson Edagwa, PhD


Benson Edegwa is co-Founder of Exavir Therapeutics, and an Associate Professor at the University of Nebraska Medical Center. The goal of Dr. Benson Edagwa’s research is to transform short acting therapies into novel ultra-long-acting safe medicines to facilitate prevention and treatment of chronic infections. His volunteer experiences in helping patients living with HIV/AIDS in Africa shaped his career goals. Benson has an extensive background in drug delivery, medicinal chemistry, and pharmacology that includes development of new strategies for the synthesis of biologically active natural products and their unnatural analogs. He has equal expertise in the design, development, and evaluation of ultra-long-acting formulations. Benson is listed as an author or major contributor to over 60 biomedical publications in peer-reviewed journals and 82 US and Worldwide patents and patent applications. His work has won numerous Awards.